These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3235216)

  • 1. High levels of tricyclic antidepressants in conventional therapy: determinant factors.
    Tamayo M; Fernández de Gatta MM; Gutierrez JR; García MJ; Domínguez-Gil A
    Int J Clin Pharmacol Ther Toxicol; 1988 Oct; 26(10):495-9. PubMed ID: 3235216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tricyclic antidepressants dosage and depressed elderly inpatients: a retrospective pharmaco-epidemiologic study].
    Ballon N; Siobud-Dorocant E; Even C; Slama F; Dardennes R
    Encephale; 2001; 27(4):373-6. PubMed ID: 11686060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excess fatality from desipramine and dosage recommendations.
    Amitai Y; Frischer H
    Ther Drug Monit; 2004 Oct; 26(5):468-73. PubMed ID: 15385827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fluoxetine and tricyclic antidepressants: clinical tolerance in short-term combined administration].
    Bonin B; Bertschy G; Baumann P; Francois T; Vandel P; Vandel S; Sechter D; Bizouard P
    Encephale; 1996; 22(3):221-7. PubMed ID: 8767051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tricyclic antidepressant concentrations in plasma: an estimate of their sensitivity and specificity as a predictor of response.
    Perry PJ; Zeilmann C; Arndt S
    J Clin Psychopharmacol; 1994 Aug; 14(4):230-40. PubMed ID: 7962678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels of tricyclic antidepressants and clinical efficacy: review of the literature -- part II.
    Risch SC; Huey LY; Janowsky DS
    J Clin Psychiatry; 1979 Feb; 40(2):58-69. PubMed ID: 581671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Grapefruit juice as a contraindication? An approach in psychiatry].
    Vandel P; Regina W; Reix I; Vandel S; Sechter D; Bizouard P
    Encephale; 1999; 25(1):67-71. PubMed ID: 10205736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Toxic tricyclic drug plasma level caused by fluoxetine].
    Hambrecht M
    Psychiatr Prax; 1995 Nov; 22(6):252-3. PubMed ID: 8570758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tricyclic antidepressants: plasma levels and clinical findings in overdose.
    Bailey DN; Van Dyke C; Langou RA; Jatlow PI
    Am J Psychiatry; 1978 Nov; 135(11):1325-8. PubMed ID: 707629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma concentrations of tricyclic antidepressants in clinical practice.
    Hollister LE
    J Clin Psychiatry; 1982 Feb; 43(2):66-9. PubMed ID: 7056706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicokinetics of nortriptyline and amitriptyline: two case reports.
    Franssen EJ; Kunst PW; Bet PM; Strack van Schijndel RJ; van Loenen AC; Wilhelm AJ
    Ther Drug Monit; 2003 Apr; 25(2):248-51. PubMed ID: 12657923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tricyclic antidepressant plasma levels after fluoxetine addition.
    Vandel S; Bertschy G; Bonin B; Nezelof S; François TH; Vandel B; Sechter D; Bizouard P
    Neuropsychobiology; 1992; 25(4):202-7. PubMed ID: 1454161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of cytochrome P4502D6 activity with paroxetine normalizes the ultrarapid metabolizer phenotype as measured by nortriptyline pharmacokinetics and the debrisoquin test.
    Laine K; Tybring G; Härtter S; Andersson K; Svensson JO; Widén J; Bertilsson L
    Clin Pharmacol Ther; 2001 Oct; 70(4):327-35. PubMed ID: 11673748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epileptic phenomena induced in the cat by the antidepressants maprotiline, imipramine, clomipramine, and amitriptyline.
    Koella WP; Glatt A; Klebs K; Dürst T
    Biol Psychiatry; 1979 Jun; 14(3):485-97. PubMed ID: 476233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poisoning by tricyclic antidepressant drugs: general and pharmacokinetic considerations.
    Bickel MH
    Int J Clin Pharmacol Biopharm; 1975 Mar; 11(2):145-76. PubMed ID: 237840
    [No Abstract]   [Full Text] [Related]  

  • 16. Placental passage of tricyclic antidepressants.
    Loughhead AM; Stowe ZN; Newport DJ; Ritchie JC; DeVane CL; Owens MJ
    Biol Psychiatry; 2006 Feb; 59(3):287-90. PubMed ID: 16271264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Convulsions observed during administration of antidepressants].
    Fukunishi I; Yamaguchi F; Hayabara T; Hosokawa K
    Rinsho Shinkeigaku; 1989 Mar; 29(3):306-9. PubMed ID: 2752657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of divalproex sodium on amitriptyline and nortriptyline pharmacokinetics.
    Wong SL; Cavanaugh J; Shi H; Awni WM; Granneman GR
    Clin Pharmacol Ther; 1996 Jul; 60(1):48-53. PubMed ID: 8689811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of an HPLC method for the monitoring of tricyclic antidepressants in biofluids.
    Samanidou VF; Nika MK; Papadoyannis IN
    J Sep Sci; 2007 Oct; 30(15):2391-400. PubMed ID: 17625794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Different effects of tricyclic (clomipramine and amitriptyline) and tetracyclic (maprotiline) antidepressors on the release of thyroid stimulating hormone, prolactin and growth hormone to thyrostimulating releasing hormone in patients with psychoaffective disorders (author's transl)].
    Schlienger JL; Kapfer MT; Singer L; Stephan F
    Acta Psychiatr Belg; 1980; 80(5):584-99. PubMed ID: 6786002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.